Literature DB >> 16481885

From big fat cells to high blood pressure: a pathway to obesity-associated hypertension.

Zdenka Pausova1.   

Abstract

PURPOSE OF REVIEW: The environment created by modern industrialized societies has caused an unprecedented rise in the prevalence of obesity and obesity-related disorders, including hypertension. Mechanisms that underlie the development of hypertension in obese individuals are not very well understood; they are thought to involve activation of the sympathetic nervous system, the renin-angiotensin-aldosterone system, and oxidative stress. RECENT
FINDINGS: Recent research suggests that obesity-associated hypertension may be causally related to the accumulation of 'dysfunctional' adipose tissue characterized by the presence of 'large' lipid-laden adipocytes.
SUMMARY: Excess energy-intake leads to an expansion of adipose tissue, a hallmark of obesity. But morphology of the expanded adipose tissue differs across individuals, including the size of adipocytes. The presence of 'large' rather than 'small' adipocytes is associated with functional and structural abnormalities of adipose tissue. These include increased production of bioactive molecules, such as leptin, angiotensinogen, pro-inflammatory cytokines, and reactive oxygen species; insufficient capacity to accommodate excess energy-intake leading to ectopic fat storage in tissues and in turn insulin resistance and hyperinsulinemia; and augmented macrophage infiltration enhancing the production of pro-inflammatory cytokines and reactive oxygen species. Such a 'dysfunctional' adipose tissue may, in turn, induce activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system and oxidative stress and, hence, promote the development of obesity-associated hypertension.

Entities:  

Mesh:

Year:  2006        PMID: 16481885     DOI: 10.1097/01.mnh.0000214775.42103.a5

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  30 in total

1.  Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adults.

Authors:  Jennifer N Cooper; Linda Fried; Ping Tepper; Emma Barinas-Mitchell; Molly B Conroy; Rhobert W Evans; Maria Mori Brooks; Genevieve A Woodard; Kim Sutton-Tyrrell
Journal:  Hypertens Res       Date:  2013-05-09       Impact factor: 3.872

2.  Up-regulation of Toll-like receptor 4/nuclear factor-kappaB signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese sheep at late gestation.

Authors:  Xu Yan; Mei J Zhu; Wei Xu; Jun F Tong; Stephen P Ford; Peter W Nathanielsz; Min Du
Journal:  Endocrinology       Date:  2009-11-03       Impact factor: 4.736

3.  Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice.

Authors:  Mutsuko Ohnishi; Shigeko Kato; M Shawkat Razzaque
Journal:  Biochem Biophys Res Commun       Date:  2011-10-20       Impact factor: 3.575

Review 4.  A Review of the Genetics of Hypertension with a Focus on Gene-Environment Interactions.

Authors:  R J Waken; Lisa de Las Fuentes; D C Rao
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

5.  Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats.

Authors:  Michaël Shum; Sandra Pinard; Marie-Odile Guimond; Sébastien M Labbé; Claude Roberge; Jean-Patrice Baillargeon; Marie-France Langlois; Mathias Alterman; Charlotta Wallinder; Anders Hallberg; André C Carpentier; Nicole Gallo-Payet
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-13       Impact factor: 4.310

6.  Underdiagnosis of Metabolic Syndrome in Non-Hispanic Black Adolescents: A Call for Ethnic-Specific Criteria.

Authors:  Mark D Deboer
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-07-01

7.  Predictive performance of lipid accumulation product and visceral adiposity index for renal function decline in non-diabetic adults, an 8.6-year follow-up.

Authors:  Pouria Mousapour; Maryam Barzin; Majid Valizadeh; Maryam Mahdavi; Fereidoun Azizi; Farhad Hosseinpanah
Journal:  Clin Exp Nephrol       Date:  2019-11-16       Impact factor: 2.801

8.  Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women.

Authors:  Apurva A Motivala; Patricia A Rose; H Myra Kim; Yolanda R Smith; Catherine Bartnik; Robert D Brook; Otto Muzik; Claire S Duvernoy
Journal:  J Nucl Cardiol       Date:  2008-04-08       Impact factor: 5.952

9.  Genetic locus on rat chromosome 20 regulates diet-induced adipocyte hypertrophy: a microarray gene expression study.

Authors:  Céline Bourdon; Silvie Hojna; Melissa Jordan; Julie Bérubé; Vladimír Kren; Michal Pravenec; Peter Liu; Sara Arab; Zdenka Pausová
Journal:  Physiol Genomics       Date:  2009-04-21       Impact factor: 3.107

Review 10.  Is adiposopathy (sick fat) an endocrine disease?

Authors:  H E Bays; J M González-Campoy; R R Henry; D A Bergman; A E Kitabchi; A B Schorr; H W Rodbard
Journal:  Int J Clin Pract       Date:  2008-08-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.